Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2001 3
2002 3
2003 6
2004 4
2005 5
2006 2
2007 9
2008 4
2009 5
2010 12
2011 7
2012 1
2013 8
2014 10
2015 11
2016 7
2017 9
2018 7
2019 6
2020 2
2021 3
2022 3
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 23769990

105 results

Results by year

Filters applied: . Clear all
Page 1
Fludarabine and 2-Gy TBI is superior to 2 Gy TBI as conditioning for HLA-matched related hematopoietic cell transplantation: a phase III randomized trial.
Kornblit B, Maloney DG, Storb R, Storek J, Hari P, Vucinic V, Maziarz RT, Chauncey TR, Pulsipher MA, Bruno B, Petersen FB, Bethge WA, Hübel K, Bouvier ME, Fukuda T, Storer BE, Sandmaier BM. Kornblit B, et al. Biol Blood Marrow Transplant. 2013 Sep;19(9):1340-7. doi: 10.1016/j.bbmt.2013.06.002. Epub 2013 Jun 11. Biol Blood Marrow Transplant. 2013. PMID: 23769990 Free PMC article. Clinical Trial.
Non-myeloablative allogeneic hematopoietic cell transplantation following fludarabine plus 2 Gy TBI or ATG plus 8 Gy TLI: a phase II randomized study from the Belgian Hematological Society.
Baron F, Zachée P, Maertens J, Kerre T, Ory A, Seidel L, Graux C, Lewalle P, Van Gelder M, Theunissen K, Willems E, Emonds MP, De Becker A, Beguin Y. Baron F, et al. J Hematol Oncol. 2015 Feb 6;8:4. doi: 10.1186/s13045-014-0098-9. J Hematol Oncol. 2015. PMID: 25652604 Free PMC article. Clinical Trial.
Low-dose total body irradiation and fludarabine conditioning for HLA class I-mismatched donor stem cell transplantation and immunologic recovery in patients with hematologic malignancies: a multicenter trial.
Nakamae H, Storer BE, Storb R, Storek J, Chauncey TR, Pulsipher MA, Petersen FB, Wade JC, Maris MB, Bruno B, Panse J, Petersdorf E, Woolfrey A, Maloney DG, Sandmaier BM. Nakamae H, et al. Biol Blood Marrow Transplant. 2010 Mar;16(3):384-94. doi: 10.1016/j.bbmt.2009.11.004. Epub 2009 Nov 10. Biol Blood Marrow Transplant. 2010. PMID: 19900571 Free PMC article. Clinical Trial.
Higher Total Body Irradiation Dose Intensity in Fludarabine/TBI-Based Reduced-Intensity Conditioning Regimen Is Associated with Inferior Survival in Non-Hodgkin Lymphoma Patients Undergoing Allogeneic Transplantation.
Hamadani M, Khanal M, Ahn KW, Litovich C, Chow VA, Eghtedar A, Karmali R, Winter A, Fenske TS, Sauter C, Kharfan-Dabaja MA, Awan FT. Hamadani M, et al. Biol Blood Marrow Transplant. 2020 Jun;26(6):1099-1105. doi: 10.1016/j.bbmt.2020.02.025. Epub 2020 Mar 9. Biol Blood Marrow Transplant. 2020. PMID: 32165327 Free PMC article.
A well-tolerated regimen of 800 cGy TBI-fludarabine-busulfan-ATG for reliable engraftment after unmanipulated haploidentical peripheral blood stem cell transplantation in adult patients with acute myeloid leukemia.
Yahng SA, Kim JH, Jeon YW, Yoon JH, Shin SH, Lee SE, Cho BS, Eom KS, Kim YJ, Lee S, Min CK, Cho SG, Kim DW, Lee JW, Min WS, Park CW, Kim HJ. Yahng SA, et al. Biol Blood Marrow Transplant. 2015 Jan;21(1):119-29. doi: 10.1016/j.bbmt.2014.09.029. Epub 2014 Oct 6. Biol Blood Marrow Transplant. 2015. PMID: 25300871 Free article.
Related and unrelated nonmyeloablative hematopoietic stem cell transplantation for malignant diseases.
Georges GE, Maris M, Sandmaier BM, Malone DG, Feinstein L, Niederweiser D, Shizuru JA, McSweeney PA, Chauncey TR, Agura E, Little MT, Sahebi F, Hegenbart U, Pulsipher MA, Bruno B, Forman S, Woolfrey AE, Radich JP, Blume KG, Storb R. Georges GE, et al. Int J Hematol. 2002 Aug;76 Suppl 1:184-9. doi: 10.1007/BF03165242. Int J Hematol. 2002. PMID: 12430851 Clinical Trial.
Reduced-Intensity Conditioning with Fludarabine, Melphalan, and Total Body Irradiation for Allogeneic Hematopoietic Cell Transplantation: The Effect of Increasing Melphalan Dose on Underlying Disease and Toxicity.
Chen GL, Hahn T, Wilding GE, Groman A, Hutson A, Zhang Y, Khan U, Liu H, Ross M, Bambach B, Higman M, Neppalli V, Sait S, Block AW, Wallace PK, Singh AK, McCarthy PL. Chen GL, et al. Biol Blood Marrow Transplant. 2019 Apr;25(4):689-698. doi: 10.1016/j.bbmt.2018.09.042. Epub 2018 Oct 6. Biol Blood Marrow Transplant. 2019. PMID: 30300731 Free PMC article.
105 results